Company: Amgen Inc.
Job title: Executive Director of Immunotherapeutics
Assessing the Advantages of Using Bispecific Antibodies to Target Specific Killing 12:30 pm
Balancing genetic engineering with manufacturing of gamma delta Vd2 cells Engineering for bispecific antibody secretion to enable interaction of other immune cells in the tumor microenvironment Engaging other immune cells using cross reactive T-cell engagersRead more
day: Conference Day Two - Morning Track A